MA35730B1 - Nouveaux supports d'agent actif à libération contrôlée, à enrobage - Google Patents

Nouveaux supports d'agent actif à libération contrôlée, à enrobage

Info

Publication number
MA35730B1
MA35730B1 MA37114A MA37114A MA35730B1 MA 35730 B1 MA35730 B1 MA 35730B1 MA 37114 A MA37114 A MA 37114A MA 37114 A MA37114 A MA 37114A MA 35730 B1 MA35730 B1 MA 35730B1
Authority
MA
Morocco
Prior art keywords
coating
new active
calcium carbonate
natural
release
Prior art date
Application number
MA37114A
Other languages
English (en)
Inventor
Patrick A C Gane
Patrick Schwarzentruber
Maiuta Nicola Di
Joachim Schoelkopf
Catherine Jean Ridgway
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/072161 external-priority patent/WO2013068478A1/fr
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of MA35730B1 publication Critical patent/MA35730B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Paints Or Removers (AREA)

Abstract

La présente invention concerne des supports pour la libération contrôlée d'agents actifs, comprenant un noyau, comprenant du carbonate de calcium naturel ou synthétique ayant réagi en surface, et au moins un agent actif, ledit ou lesdits agent(s) actif(s) étant associé(s) audit carbonate de calcium ayant réagi en surface, naturel ou synthétique, et ledit carbonate de calcium naturel ou synthétique, ayant réagi en surface, étant un produit de réaction de carbonate de calcium naturel ou synthétique avec du dioxyde de carbone et un ou plusieurs acide(s), le dioxyde de carbone étant formé
MA37114A 2011-11-10 2014-06-06 Nouveaux supports d'agent actif à libération contrôlée, à enrobage MA35730B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (fr) 2011-11-10 2011-11-10 Nouveaux supports revêtus d'agent actif à libération contrôlée
PCT/EP2012/072161 WO2013068478A1 (fr) 2011-11-10 2012-11-08 Nouveaux supports d'agent actif à libération contrôlée, à enrobage

Publications (1)

Publication Number Publication Date
MA35730B1 true MA35730B1 (fr) 2014-12-01

Family

ID=44992702

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37114A MA35730B1 (fr) 2011-11-10 2014-06-06 Nouveaux supports d'agent actif à libération contrôlée, à enrobage

Country Status (3)

Country Link
EP (2) EP2591772B1 (fr)
MA (1) MA35730B1 (fr)
TN (1) TN2014000141A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109071750B (zh) 2016-03-08 2022-08-02 生活实验公司 持久化妆品组合物
CN111133023B (zh) 2017-09-13 2022-10-18 生活实验公司 持久化妆品组合物
CA3074845A1 (fr) 2017-09-13 2019-03-21 Living Proof, Inc. Compositions de protection de couleur
CN111356501A (zh) 2017-11-20 2020-06-30 生活实验公司 实现持久化妆品性能的属性
CN109846043B (zh) * 2017-11-30 2023-04-07 内蒙古伊利实业集团股份有限公司 一种结肠缓释益生菌及其制备方法
AU2019257739B2 (en) 2018-04-27 2025-01-09 Living Proof, Inc. Long lasting cosmetic compositions
WO2020091456A1 (fr) 2018-10-31 2020-05-07 ㈜아모레퍼시픽 Structure de réseau cœur-écorce comprenant un biopolymère et composition comprenant celle-ci
KR102739456B1 (ko) * 2018-10-31 2024-12-09 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
KR102936013B1 (ko) 2019-12-03 2026-03-10 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
EP3928859A1 (fr) 2020-06-23 2021-12-29 Omya International AG Carbonate de calcium traité par réaction en surface dans un procédé de production d'une microcapsule chargée

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (fr) 2006-08-25 2008-02-27 Novartis AG Formulations galéniques de l'aliskiren
DE602007005093D1 (de) * 2007-03-21 2010-04-15 Omya Development Ag Verfahren zur Beseitigung von endokrin wirksamen Verbindungen
PT2070991E (pt) 2007-12-12 2010-10-25 Omya Development Ag Processo para produção de carbonato de cálcio precipitado reagido em superfície
EP2168572A1 (fr) * 2008-09-30 2010-03-31 Omya Development Ag Nouveau support d'agent actif à libération contrôlée
WO2010121620A1 (fr) 2009-04-24 2010-10-28 Fertin Pharma A/S Matière particulaire pour la libération contrôlée de principes actifs
EP2264108B1 (fr) 2009-06-15 2012-02-15 Omya Development AG Procédé pour la préparation d'un carbonate de calcium réagi en surface utilisant un acide faible
DK2264109T3 (da) 2009-06-15 2012-05-21 Omya Development Ag Fremgangsmåde til fremstilling af overfladereaktivt calciumcarbonat og dets anvendelse

Also Published As

Publication number Publication date
EP2591772A1 (fr) 2013-05-15
TN2014000141A1 (en) 2015-09-30
EP3075376A1 (fr) 2016-10-05
EP2591772B1 (fr) 2016-05-04

Similar Documents

Publication Publication Date Title
MA35730B1 (fr) Nouveaux supports d'agent actif à libération contrôlée, à enrobage
ME03347B (fr) Compositions antiparasitaires comprenant un agent actif d'isoxazoline, procédés et utilisations associés
UA104601C2 (uk) Модулятори регулятора трансмембранної провідності при муковісцидозі
UA107103C2 (uk) Нікотиновмісні м'які желатинові пастилки
MX346884B (es) Nuevos portadores recubiertos de agente activo de liberacion controlada.
WO2011106322A3 (fr) Biomarqueurs pour accident ischémique cérébral aigu
MA29816B1 (fr) Composes de benzimidazole thiophene
BR112012016749A2 (pt) "d-aminoácido para uso no tratamento de biofilmes"
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
EA201290041A1 (ru) Лечение расстройств, связанных с макрофагами
MA34818B1 (fr) Anticorps anti-pcsk9 et procédés d'utilisation
MX388981B (es) Inhibidores de enzima 1 dependiente de inositol (ire-1alfa).
GB2460597A (en) N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
EP2588121A4 (fr) Analogues de c5a et procédés d'utilisation associés
NO20076405L (no) Anvendelse av 24-nor-UDCA
BR112012007888A2 (pt) "métodos de tratamento usando anticorpos anti-ldl oxidada".
NZ609144A (en) Methods of treating eye diseases associated with inflammation and vascular proliferation
GEP20125680B (en) Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydra-zinium) ropionate esters and their use for 3-(2,2,2-rimethyl- hydrazinium) propionate dihydrate preparation
DE502008002255D1 (de) Arzneimittel enthaltend Fraumenmantel zur Behandlung von Endometritis, Vaginitis
WO2011127244A8 (fr) Formulations de sulfate d'atazanavir avec un effet ph amélioré
UA103747C2 (ru) Ароматические соединения с повышенной стабильностью
SG195170A1 (en) Methods of treating or preventing rheumatic disease
EA201300719A3 (ru) Способ ферментативного синтеза (7s)-1-(3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил) n-метилметанамина, и применение в синтезе ивабрадина и его солей
TW200738752A (en) Modulation of MDL-1 activity for treatment of inflammatory disease
MX344965B (es) Preparacion de (r) y (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilam ino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopropan-1-sulfonam ida y derivados protegidos de los mismos.